AIBN researchers scored four wins in the latest Investigator Grant round for nanotechnology projects that could change the way we approach certain diseases.
AIBN researchers want HIV patients to have the option of taking a long-acting antiretroviral dose once a week, instead of having to take a dose every day.
Researchers have developed a new approach to delivering DNA into cells using spikey silica nanoparticles. These nanoparticles transport the genetic cargo across the cell wall while protecting it from degradation.
